A nurse holds a COVID-19 vaccine in Miami, Fla., in this file photograph. Joe Raedle/Getty ImagesPfizer reported a decline in revenue on Nov. 4, which it primarily attributed to lower sales for the company’s COVID-19 vaccine, Comirnaty, and COVID-19 drug, Paxlovid.The company said it made $16.7 billion in revenue in the third quarter, down 7 percent from Q3 2024.
Date:
More like thisRelated
US Dollar Strengthens to Highest Point in Half a Year
The greenback rose to a four-month high against the...
Supreme Court to Decide on Trumps Tariffs: 6 Things to Know
The court will determine the fate of Trump’s global...
Cybersecurity Agents Accused of Working With Notorious Blackcat Hackers to Extort Firms
In this photo illustration, a hacker types on a...